Aging isn't about worn-out parts—it's about cells that have forgotten how to function. Neo Prometheus Protocol doesn't replace your cells; it updates their operating system.
Built on ongoing translational research across cellular biology, epigenetics, metabolism, and immunology.
Senolytics
Senescent cells accumulate with age and are one area of active longevity research. NovaGen Group studies how cellular programs may be characterized and monitored.
Epigenetics
DNA methylation patterns are one way researchers study cellular aging. Neo Prometheus Protocol explores epigenetic reprogramming concepts without DNA editing.
Metabolism
Mitochondrial function changes with age. Research workflows monitor energy-related markers alongside other cellular signals.
Immunology
Immune signaling is part of the broader cellular aging landscape and remains an important area for preclinical and translational research.
Request educational resources to support a discussion with your healthcare provider.
Our Team
World-Class Leadership
Led by experienced executives and guided by distinguished advisors
Leadership Team
Operators, scientists, and builders coordinating NovaGen Group's research-led platform.
8 leaders
Diederik van der Reijt
Chief Executive Officer
Diederik van der Reijt is the CEO and Co-founder. A serial biotech entrepreneur and investor, he previously built a successful high-frequency trading firm and co-founded NKore Biotherapeutics, and now leverages his finance and venture capital background to democratize access to breakthrough cellular therapies.
Dr. Yi Eve Sun
Chief Scientific Officer
Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.
Dr. Henk Viëtor
Chief Medical Officer
Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.
Karen Brink
Chief Growth Officer
Karen Brink leads growth strategy and thought leadership for the company’s cellular longevity platform. An experienced healthcare investor and company founder, she has launched several healthcare ventures and holds a Blockchain Strategy degree from Oxford.
Jimmy Zhu Wenmin
Chief Innovation Officer
Seasoned business professional with a strong track record in commercializing innovative healthcare technologies in China. Proven leader in scaling ventures, securing strategic partnerships, and driving global market expansion.
Dr. Digvijay Gahtory
Chief Business Officer
Has over 8 years of experience in strategy consulting and entrepreneurship. Has raised more than €100 million in financing for life science companies. Founder and CEO of Bimini Biotech.
Rhys Tombling
Finance Director
Has 10 years of experience in the private sector, specializing in financial control & operations for start-ups and scale-ups in FMCG and SaaS. Holds an ACA-ICAEW accountancy qualification and a BA in Accountancy and Finance from Newcastle University.
Daniel Erasmus
Chief AI Architect
He is a member of the OECD's AI Expert Group and CEO of Erasmus.AI, a platform creating domain-specific AI models like ClimateGPT, the world's first foundational Climate Change model. With 25 years of experience in strategy and foresight advisory, he is also a full member of the Club of Rome.
Medical & Scientific Board
Scientific and clinical advisors supporting research context and review.
5 members
Dr. Henry Delmar
Founder Clinique Delmar
Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.
Dr. Pierre Maldiney
Cardiologist & Functional Medicine Doctor
Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.
Dr. Bas Pijnenburg
Orthopedic Surgeon & Medical Director Acibadem (NL)
Orthopedic surgeon at ACIBADEM International Medical Center with expertise in hip, knee, and ankle conditions, including sports orthopedics and arthroscopic treatment of ankle and knee injuries. He trained in medicine and orthopedics in Amsterdam and completed a PhD on evidence-based diagnosis and treatment of acute ankle injuries.
Doris Rathgeber
Owner, Body & Soul
Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.
Dr. Heshan Illangkoon
Biochemist & Regenerative Medicine
Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads NovaGen Group's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.
Advisory Board
Global advisors across finance, partnerships, governance, and cross-border strategy.
8 members
Neil Bush
Strategic/ Cross Border Advisor
Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.
Dr. Nina Storms (h.c.)
Strategic Advisor
Entrepreneur and strategic investor with a background in technology, internet, media, and health ventures. She founded multiple companies, later invested across media and internet companies, and is now involved with NovaGen’s regenerative longevity platform.
Jaap Zuiderveld
Global Technology Advisor
International technology executive with more than 20 years of leadership experience across AI, software, IT, and telecommunications. He has held senior roles at NVIDIA, Colt Technology Services, ACN, Active 24, Versatel, KPN, and British Telecom, with a focus on scaling regional growth and AI adoption.
Dr. Marcel Reichart
Capital Market Advisor
Is a global senior advisor, executive and investor with extensive experience in international corporate development, M&A, board management, capital markets and communications across technology, AI, software, media, blockchain and growth industries.
Stephen Bradley
Advisor
Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.
Paul Spiegel
Advisor
International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.
David Bizer
Advisor
Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.
Shirin Azad
Advisor
Shirin Azad is Strategic Advisor for Europe where she supports the company’s mission to advance investigational cellular longevity technologies. Based in London, she is an ex-headhunter, investor, and philanthropist with international experience across the UK and Germany, and she brings a strong interest in health, longevity, and patient advocacy to her work.
Questions & Answers
Frequently Asked Questions
Everything you need to know about Neo Prometheus Protocol
Can't find what you're looking for? Contact our specialist team
Important Medical Notice: Content on this website is educational and informational only. NovaGen Group does not provide medical advice, diagnosis, or treatment through this website. Any investigational protocol information should be discussed with qualified, licensed healthcare professionals. Availability and regulatory status vary by jurisdiction.